INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 44h ago
House PTR4h ago
SEC 13F4h ago
Robinhood Chain4h ago

Results

20,303 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
13
FR
Fukushima RyanCEO, Data
TEMTempus AI, Inc.
Open-market sale · 10b5-1 plan
SELL$49K
700 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

Page 107 of 508
← PrevNext →
12
ZR
Zage George Raymond IIIDirector, 10% Owner
GRNDGrindr Inc.
Open-market sale · 10b5-1 plan
SELL
$2.56M
166.4K sh
Sep 17, 2026
Sep 18, 2026
traded Sep 17, 2026
+1d
SEC Form 4

Evidence

11
NJ
Nicholas Christopher JamesExecutive Vice President
WMTWalmart Inc.
Open-market sale · 10b5-1 plan
SELL$149K
1,395 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

11
NJ
Nicholas Christopher JamesExecutive Vice President
WMTWalmart Inc.
Open-market sale · 10b5-1 plan
SELL$160K
1,505 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

11
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$2.89M
30.0K sh
Sep 18, 2026Sep 18, 2026
traded Sep 18, 2026
+0dSEC Form 4

Evidence

11
Sahin UgurChief Executive Officer, 10% Owner
BNTXBioNTech SE
Open-market sale · 10b5-1 plan
SELL$3.35M
34.0K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

10
CM
Cummings MarthaDirector
MQMarqeta, Inc.
Open-market sale · 10b5-1 plan
SELL$11K
713 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
WL
Wang LingkeDirector, President
LIFEEthos Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$285K
7,431 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

9
CG
Colis Peter GeorgeDirector, CEO and Secretary
LIFEEthos Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$822K
21.1K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

9
SR
Sullivan Christopher RyanChief Financial Officer
AVTXAvalo Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$202K
12.4K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
CG
Colis Peter GeorgeDirector, CEO and Secretary
LIFEEthos Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$259K
7,190 sh
Sep 18, 2026Sep 18, 2026
traded Sep 18, 2026
+0dSEC Form 4

Evidence

9
CG
Colis Peter GeorgeDirector, CEO and Secretary
LIFEEthos Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$850K
21.4K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

9
CG
Colis Peter GeorgeDirector, CEO and Secretary
LIFEEthos Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$357K
9,648 sh
Sep 18, 2026Sep 18, 2026
traded Sep 18, 2026
+0dSEC Form 4

Evidence

7
EM
Eisen Anthony MathewDirector
XYZBlock, Inc.
Open-market sale · 10b5-1 plan
SELL$468K
6,000 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

7
EM
Eisen Anthony MathewDirector
XYZBlock, Inc.
Open-market sale · 10b5-1 plan
SELL$470K
6,000 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

7
EM
Eisen Anthony MathewDirector
XYZBlock, Inc.
Open-market sale · 10b5-1 plan
SELL$459K
6,000 sh
Sep 18, 2026Sep 18, 2026
traded Sep 18, 2026
+0dSEC Form 4

Evidence

6
CG
Colis Peter GeorgeDirector, CEO and Secretary
LIFEEthos Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$72K
1,900 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

6
CG
Colis Peter GeorgeDirector, CEO and Secretary
LIFEEthos Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$244K
6,495 sh
Sep 18, 2026Sep 18, 2026
traded Sep 18, 2026
+0dSEC Form 4

Evidence

6
CG
Colis Peter GeorgeDirector, CEO and Secretary
LIFEEthos Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$80K
1,971 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

5
HK
Hanson KristopherGeneral Counsel
MPLTMapLight Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$193K
16.5K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

4
LF
Lo FrancisChief People Officer
ADPTAdaptive Biotechnologies Corp
Open-market sale · 10b5-1 plan
SELL$225K
7,869 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

4
OO
Offer OrChief Executive Officer
SMWBSIMILARWEB LTD.
Open-market sale · 10b5-1 plan
SELL$384K
45.7K sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

4
OO
Offer OrChief Executive Officer
SMWBSIMILARWEB LTD.
Open-market sale · 10b5-1 plan
SELL$254K
30.4K sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

3
CG
Colis Peter GeorgeDirector, CEO and Secretary
LIFEEthos Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$12K
315 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

3
WL
Wang LingkeDirector, President
LIFEEthos Technologies Inc.
Open-market sale · 10b5-1 plan
SELL$12K
315 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

3
SE
Song EstherSee Remarks
SYNASYNAPTICS Inc
Open-market sale · 10b5-1 plan
SELL$5,836
63 sh
Sep 18, 2026Sep 18, 2026
traded Sep 18, 2026
+0dSEC Form 4

Evidence

3
AL
Azar Samak LChief Legal Officer
GFSGLOBALFOUNDRIES Inc.
Open-market sale · 10b5-1 plan
SELL$15K
335 sh
Sep 17, 2026Sep 18, 2026
traded Sep 17, 2026
+1dSEC Form 4

Evidence

1
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$77K
460 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

1
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$57K
345 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

1
MM
Matsuda MasaruSee Remarks
ARQTArcutis Biotherapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$92K
3,674 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

0
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$688
4 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

0
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$40K
234 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

0
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$32K
191 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

0
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$17K
103 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

0
NT
Navratil TomasCHIEF DEVELOPMENT OFFICER
GKOSGLAUKOS Corp
Open-market sale · 10b5-1 plan
SELL$20K
120 sh
Sep 16, 2026Sep 18, 2026
traded Sep 16, 2026
+2dSEC Form 4

Evidence

55
BJ
Brille Brian JDirector, See Remarks
CAICaris Life Sciences, Inc.
Open-market sale
SELL$12.13M
400.0K sh
Sep 17, 2026Sep 17, 2026
traded Sep 17, 2026
+0dSEC Form 4

Evidence

50
BR
Boyle RobertSVP, GC and Secretary
PHINPHINIA INC.
Open-market sale
SELL$466K
7,500 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

43
OG
Omer GalCLO
NYAXNayax Ltd.
Open-market sale
SELL$68K
1,500 sh
Sep 16, 2026Sep 17, 2026
traded Sep 16, 2026
+1dSEC Form 4

Evidence

41
FD
Fortunato DavidDirector, CEO and President
WLTHWEALTHFRONT CORP
Open-market sale
SELL$1.00M
93.3K sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence

40
CD
Chudova DaryaChief Technology Officer
GHGuardant Health, Inc.
Open-market sale
SELL$1.38M
7,738 sh
Sep 15, 2026Sep 17, 2026
traded Sep 15, 2026
+2dSEC Form 4

Evidence